PMID- 33343878 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201222 IS - 2045-8932 (Print) IS - 2045-8940 (Electronic) IS - 2045-8932 (Linking) VI - 10 IP - 4 DP - 2020 Oct-Dec TI - Pulmonary hypertension in patients with interstitial pneumonia with autoimmune features. PG - 2045894020944117 LID - 10.1177/2045894020944117 [doi] LID - 2045894020944117 AB - Pulmonary hypertension in interstitial lung diseases is associated with increased mortality and hospitalizations and reduced exercise capacity. Interstitial pneumonia with autoimmune features (IPAF) is a recently described interstitial lung disease. The characteristics of pulmonary hypertension in IPAF patients are unknown. We sought to characterize patients with IPAF based on their echocardiographic probability of pulmonary hypertension and compare patients with and without pulmonary hypertension identified by right heart catheterization. We conducted a retrospective study of patients seen in the interstitial lung disease clinic from 2015 to 2018. Forty-seven patients with IPAF were identified. Patients were classified into low, intermediate and high echocardiographic pulmonary hypertension probabilities. A sub-group analysis of patients with pulmonary hypertension and without pulmonary hypertension (IPAF-PH vs. IPAF-no PH) identified by right heart catheterization was also performed. Linear regression analysis was performed to study the association between 6-min-walk-distance (6MWD) and pulmonary vascular resistance (PVR) while adjusting for age and body mass index. Right ventricular hypertrophy (>5 mm), right ventricular enlargement (>41 mm) and right ventricular systolic dysfunction defined as fractional area change%